CN110231418A - A kind of method of Multiple components content in HPLC method separation determination ageratum oral liquid - Google Patents

A kind of method of Multiple components content in HPLC method separation determination ageratum oral liquid Download PDF

Info

Publication number
CN110231418A
CN110231418A CN201910524812.9A CN201910524812A CN110231418A CN 110231418 A CN110231418 A CN 110231418A CN 201910524812 A CN201910524812 A CN 201910524812A CN 110231418 A CN110231418 A CN 110231418A
Authority
CN
China
Prior art keywords
mobile phase
percent
volume
solution
oral liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910524812.9A
Other languages
Chinese (zh)
Other versions
CN110231418B (en
Inventor
郭大乐
邓赟
秦少容
陈金凤
董自亮
彭涛
李张宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAIJI GROUP CHONGQING FULING PHARMACEUTICAL FACTORY CO Ltd
Chongqing Taiji Medical Research Institute Co Ltd
Original Assignee
TAIJI GROUP CHONGQING FULING PHARMACEUTICAL FACTORY CO Ltd
Chongqing Taiji Medical Research Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAIJI GROUP CHONGQING FULING PHARMACEUTICAL FACTORY CO Ltd, Chongqing Taiji Medical Research Institute Co Ltd filed Critical TAIJI GROUP CHONGQING FULING PHARMACEUTICAL FACTORY CO Ltd
Priority to CN201910524812.9A priority Critical patent/CN110231418B/en
Publication of CN110231418A publication Critical patent/CN110231418A/en
Application granted granted Critical
Publication of CN110231418B publication Critical patent/CN110231418B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N2030/042Standards
    • G01N2030/047Standards external

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)

Abstract

The invention belongs to field of pharmaceutical preparations, are related to the method for quality control of ageratum oral liquid, and in particular to a kind of method of Multiple components content in HPLC method separation determination ageratum oral liquid.The present invention provides a kind of method of Multiple components content in HPLC method separation determination ageratum oral liquid, the chromatographic column that the HPLC method uses is mixed in a certain ratio with solution A and solution B and is eluted for mobile phase using silica matrix as filler;The solution A is acetonitrile, and the solution B is phosphoric acid water;The ingredient includes one of glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin, nobiletin or a variety of.Method of the invention is simple, sensitive, accuracy is high, can make up the defect that the prior art is not enough to illustrate component content in ageratum oral liquid, effectively ensure the quality of ageratum oral liquid.

Description

A kind of method of Multiple components content in HPLC method separation determination ageratum oral liquid
Technical field
The invention belongs to field of pharmaceutical preparations, are related to the method for quality control of ageratum oral liquid, and in particular to a kind of The method of Multiple components content in HPLC method separation determination ageratum oral liquid.
Background technique
Ageratum oral liquid is a kind of Chinese patent drug, have inducing diaphoresis dampness elimination, qi-regulating and it is middle the effect of.Chinese Pharmacopoeia first It records, prescription is by rhizoma atractylodis, Cortex Magnoliae Officinalis, Poria cocos, dried pinellia, patchouli oil, dried orange peel, the root of Dahurain angelica, the shell of areca nut, extract of licorice root and perilla leaf Oil composition, pharmacopeia also describe the high-efficiency liquid chromatography method for detecting of Cortex Magnoliae Officinalis, dried orange peel and perilla leaf oil simultaneously.In addition, existing text Offer in data, Yu Jiawen et al. establish while measuring aurantiamarin in ageratum oral liquid, narirutin, honokiol, Magnolol, liquiritin, ammonium glycyrrhetate content UPLC analysis method, to control dried orange peel in preparation, Cortex Magnoliae Officinalis and extract of licorice root;Wang Jiao Et al. establish while measuring aurantiamarin in ageratum oral liquid, Imperatorin, Isomperatorin, magnolol, honokiol, The HPLC analysis method of rhizoma atractylodis cellulose content.The content that the above technical manual and disclosed documents and materials are recorded is not enough to illustrate the leaves of pulse plants The content of ingredient in fragrant positive invigorating oral liquid.
Therefore, the present invention establishes a kind of HPLC analysis method to measure many indexes ingredient in ageratum oral liquid, The present invention can provide scientific experiment foundation for the foundation of ageratum oral liquid global quality control appraisement system.
Summary of the invention
In consideration of it, one of the object of the invention, it is to provide a variety of in a kind of HPLC method separation determination ageratum oral liquid Component content.
A kind of method of Multiple components content in HPLC method separation determination ageratum oral liquid, what the HPLC method used Chromatographic column is mixed in a certain ratio with solution A and solution B and is eluted for mobile phase using silica matrix as filler;It is described molten Liquid A is acetonitrile, and the solution B is phosphoric acid water;The ingredient includes glycycoumarin, isoliquiritigenin, celery sugar liquiritin, shaddock ped rue One of fragrant glycosides, liquiritin, nobiletin are a variety of.
Further, the mass concentration of the phosphoric acid water is 0.05%-0.15%.
As a preference, the mass concentration of the phosphoric acid water is 0.05%.
Further, it is 0.5-1.5ml/min that the mobile phase, which carries out the flow velocity of gradient elution,.
As a preference, the flow velocity that the mobile phase carries out gradient elution is 1.0ml/min.
Further, detector wavelength 250-280nm.
As a preference, detector wavelength is 280nm.
Further, detector column temperature is 25-30 DEG C.
As a preference, detector column temperature is 25 DEG C.
Further, condition of gradient elution are as follows:
The percent by volume of 0-10min, mobile phase A and Mobile phase B is 8-18:92-82;
The percent by volume of 10-15min, mobile phase A and Mobile phase B is 18-19:82-81;
The percent by volume of 15-17min, mobile phase A and Mobile phase B is 19:81;
The percent by volume of 17-23min, mobile phase A and Mobile phase B is 19-20:81-80;
The percent by volume of 23-27min, mobile phase A and Mobile phase B is 20:80;
The percent by volume of 27-30min, mobile phase A and Mobile phase B is 20-21:80-79;
The percent by volume of 30-35min, mobile phase A and Mobile phase B is 21:79;
The percent by volume of 35-38min, mobile phase A and Mobile phase B is 21-22:79-78;
The percent by volume of 38-41min, mobile phase A and Mobile phase B is 22-23:78-77;
The percent by volume of 41-45min, mobile phase A and Mobile phase B is 23-26:77-74;
The percent by volume of 45-51min, mobile phase A and Mobile phase B is 26-32:74-68;
The percent by volume of 51-54min, mobile phase A and Mobile phase B is 32-33:68-67;
The percent by volume of 54-62min, mobile phase A and Mobile phase B is 33-55:67-45;
The percent by volume of 62-72min, mobile phase A and Mobile phase B is 55-74:45-26;
The percent by volume of 72-75min, mobile phase A and Mobile phase B is 74-75:26-25;
The percent by volume of 75-77min, mobile phase A and Mobile phase B is 75:25;
The percent by volume of 77-80min, mobile phase A and Mobile phase B is 75-100:25-0;
The percent by volume of 80-83min, mobile phase A and Mobile phase B is 100:0;
The percent by volume of 83-85min, mobile phase A and Mobile phase B is 100-8:0-92.
Gradient elution is the professional term of a field of pharmaceutical preparations, is referred in the same analytical cycle, by certain journey The concentration proportioning that degree constantly changes mobile phase carrys out separate substance.In HPLC analysis, the concrete composition and its gradient of mobile phase become Change is the important parameter for realizing the separation analysis of multi-component complex sample.
The two of the object of the invention are to provide Multiple components content in a kind of HPLC method separation determination ageratum oral liquid Specific method.
According to the method for Multiple components content in a kind of above-mentioned HPLC method separation determination ageratum oral liquid, step is such as Under:
1) it prepares reference substance solution: weighing suitable glycycoumarin, isoliquiritigenin, celery sugar liquiritin, shaddock ped rue respectively Fragrant glycosides, liquiritin, nobiletin add methanol solution dissolution that reference substance solution is prepared;
2) it prepares sample solution: weighing suitable ageratum oral liquid, diluted with methanol solution and sample solution is made;
As a preference, taking ageratum oral liquid 5 of every 10mL to mix, 2mL recycling design is taken, is weighed 162.3mg, with methanol dilution to 10mL to get;
3) the sample solution injection high performance liquid chromatograph of the reference substance solution and step 2) that take step 1) respectively is divided Analysis records chromatogram, and each peak separating degree should be greater than 1.5, calculates glycycoumarin, different Radix Glycyrrhizae in sample solution using external standard method Element, celery sugar liquiritin, narirutin, liquiritin, nobiletin content.
The three of the object of the invention are to provide a kind of reagent of Multiple components content in separation determination ageratum oral liquid Composition.
It is a kind of for be separated by solid-liquid separation measurement ageratum oral liquid in Multiple components content reagent composition, the ingredient Including one of glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin, nobiletin or a variety of;Institute Reagent composition is stated using silica gel as stationary phase, using acetonitrile as reagent A, using phosphoric acid water as reagent B;The phosphoric acid water Mass concentration is 0.05%-0.15%.
As a preference, the mass concentration of the phosphoric acid water is 0.05%.
The three of the object of the invention are to provide a kind of separation determination glycycoumarin, isoliquiritigenin, celery sugar Radix Glycyrrhizae simultaneously The HPLC method of this component content in 6 of glycosides, narirutin, liquiritin, nobiletin.
A kind of separation determination glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin and river simultaneously The HPLC method of skin glycosides content, the chromatographic column that the HPLC method uses are using silica matrix as filler, with solution A and solution B It is mixed in a certain ratio and is eluted for mobile phase;The solution A is acetonitrile, and the solution B is phosphoric acid water.
Further, condition of gradient elution are as follows:
The percent by volume of 0-10min, mobile phase A and Mobile phase B is 8-18:92-82;
The percent by volume of 10-15min, mobile phase A and Mobile phase B is 18-19:82-81;
The percent by volume of 15-17min, mobile phase A and Mobile phase B is 19:81;
The percent by volume of 17-23min, mobile phase A and Mobile phase B is 19-20:81-80;
The percent by volume of 23-27min, mobile phase A and Mobile phase B is 20:80;
The percent by volume of 27-30min, mobile phase A and Mobile phase B is 20-21:80-79;
The percent by volume of 30-35min, mobile phase A and Mobile phase B is 21:79;
The percent by volume of 35-38min, mobile phase A and Mobile phase B is 21-22:79-78;
The percent by volume of 38-41min, mobile phase A and Mobile phase B is 22-23:78-77;
The percent by volume of 41-45min, mobile phase A and Mobile phase B is 23-26:77-74;
The percent by volume of 45-51min, mobile phase A and Mobile phase B is 26-32:74-68;
The percent by volume of 51-54min, mobile phase A and Mobile phase B is 32-33:68-67;
The percent by volume of 54-62min, mobile phase A and Mobile phase B is 33-55:67-45;
The percent by volume of 62-72min, mobile phase A and Mobile phase B is 55-74:45-26;
The percent by volume of 72-75min, mobile phase A and Mobile phase B is 74-75:26-25;
The percent by volume of 75-77min, mobile phase A and Mobile phase B is 75:25;
The percent by volume of 77-80min, mobile phase A and Mobile phase B is 75-100:25-0;
The percent by volume of 80-83min, mobile phase A and Mobile phase B is 100:0;
The percent by volume of 83-85min, mobile phase A and Mobile phase B is 100-8:0-92.
The beneficial effects of the present invention are:
1) the present invention provides a kind of methods of Multiple components content in HPLC method separation determination ageratum oral liquid, should Method is able to achieve efficiently separating for glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin and nobiletin.
2) this method is simple, sensitive, accuracy is high, can make up the prior art and be not enough to illustrate in ageratum oral liquid The defect of component content effectively ensures the quality of ageratum oral liquid.
Detailed description of the invention
Fig. 1 HPLC analyzes map.
Specific embodiment
Hereinafter reference will be made to the drawings, and the preferred embodiment of the present invention is described in detail.Illustrated embodiment is in order to more preferable Ground is illustrated the contents of the present invention, but is not that the contents of the present invention are only limitted to illustrated embodiment.So being familiar with this field Technical staff nonessential modifications and adaptations are carried out to embodiment according to foregoing invention content, still fall within protection of the invention Range.
1. laboratory apparatus
SartoriusBP211D type electronic balance (German Sai Tuolisi company);(Sichuan is excellent general super for Hyperpure water manufacturing systems Pure Science and Technology Ltd.);Sai Mo flies UltiMate 3000 (match is silent to fly).
2. experimental material
Tai Ji ageratum oral liquid (Taiji Group Chongqing Fuling Pharmaceutical Factory Co., Ltd., lot number 17080319).
The preferred Tai Ji ageratum oral liquid of the present embodiment, but the present invention is not limited to the ageratum mouths of Tai Ji pharmaceutical factory Take liquid.
Glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin, nobiletin;Methanol, acetonitrile;Two Secondary distilled water.
Embodiment 1
1. reference substance stock solution
Precision weighs glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin, appropriate nobiletin, 0.07450,0.50002,0.97600,0.50010,0.50000,0.62700mg/ml is respectively prepared after additive color spectrum methanol dissolution Reference substance stock solution, be stored in spare in 4 DEG C of refrigerators.
2. standard curve
Precision draws the glycycoumarin reference substance stock solution 1) under item, successively dilute every 1mL containing 0.0075, 0.0037,0.0019,0.0009,0.0006,0.0005mg, obtain the reference substance solution of 6 groups of various concentrations, number 1~6;It is accurate Draw the isoliquiritigenin reference substance stock solution 1) under item, successively dilute every 1mL containing 0.0250,0.0125,0.0063, 0.0031,0.0016,0.0008mg, obtain the reference substance solution of 6 groups of various concentrations, number 1~6;Precision draws the celery under 1) item Sugared liquiritin reference substance stock solution, successively dilute every 1mL containing 0.9760,0.0976,0.0488,0.0244,0.0122, 0.0061mg obtains the reference substance solution of 6 groups of various concentrations, number 1~6;Precision draws the narirutin reference substance under 1) item Stock solution, successively dilute every 1mL containing 0.2500,0.0500,0.0250,0.0125,0.0063,0.0016mg, obtain 6 groups of differences The reference substance solution of concentration, number 1~6;Precision draws the liquiritin reference substance stock solution under 1) item, successively dilutes to obtain every 1mL Containing 0.2500,0.1250,0.0625,0.0313,0.0156,0.0078mg, the reference substance solution of 6 groups of various concentrations, number 1 are obtained ~6;Precision draws the nobiletin reference substance stock solution 1) under item, successively dilute every 1mL containing 0.0627,0.0063,0.0031, 0.0016,0.0007,0.0004mL, obtain the reference substance solution of 6 groups of various concentrations, number 1~6;It measures according to the following steps.With right According to the concentration (mgmL of product-1) it is abscissa (X), peak area (mAU) is ordinate (Y), draws standard curve, obtains recurrence side Journey and related coefficient.
2.1 chromatographic conditions and system suitability Kromasil EternityXT-5-C18 column (4.6 × 250mm, 5 μm), stream Dynamic phase acetonitrile (A) -0.05% phosphoric acid water (B).Gradient elution: 0~10min, 8%~18%A;10~15min, 18%~19% A;15~17min, 19%~19%A;17~23min, 19%~20%A;23~27min, 20%~20%A;27~ 30min, 20%~21%A;30~35min, 21%~21%A;35~38min, 21%~22%A;38~41min, 22% ~23%A;41~45min, 23%~26%A;45~51min, 26%~32A;51~54min, 32%~33%A;54~ 62min, 33%~55%A;62~72min, 55%~74%A;72~75min, 74%~75%A;75~77min, 75% ~75%A;77~80min, 75%~100%A;80~83min, 100%~100%A;83~85min, 100%~8%A. Flow velocity 1mL/min;Detection wavelength 280nm;25 DEG C of column temperature;10 μ L of sample volume.Each peak separating degree is all larger than 1.5.
2.2 equation of linear regression
The equation of linear regression of 16 kinds of ingredients of table
Embodiment 2
1. precision
6 kinds of reference substance stock solutions of accurate measurement are appropriate respectively, obtain every 1mL with methanol dilution and contain 0.002,0.050,0.005, The mixed solution of the above-mentioned 6 kinds of ingredients of 0.010,0.050 and 0.003mg.10 μ L of mixed solution is taken, by embodiment 1 " 2.1 " Xiang Jinhang Measurement.Continuous sample introduction 6 times, record peak area.As a result glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, sweet Careless glycosides, nobiletin peak area RSD value be respectively 1.06%, 0.17%, 1.43%, 1.24%, 0.23%, 0.15%, 6 kinds at The RSD value of swarming area is respectively less than 3%, shows that instrument precision is good.
2. repeatability
Take 1 is 17080319 sample preparation test solution in batches number, prepares sample by method provided by the invention, then Every 1mL above-mentioned 6 kinds of ingredients Han 0.0020,0.0500,0.0050,0.0100,0.0500 and 0.0030mg are obtained with methanol dilution Test solution is mixed, is measured by embodiment 1 " 2.1 " item.As a result glycycoumarin, isoliquiritigenin, celery sugar liquiritin, shaddock ped rue Fragrant glycosides, liquiritin, nobiletin peak area RSD value be respectively 2.88%, 0.53%, 0.56%, 0.40%, 0.36%, 1.81%, the RSD value of 6 kinds of Component peak areas is respectively less than 3%, shows each ingredient weight in 48h in Tai Ji ageratum oral liquid Renaturation is good.
3. stability
Take 1 is a 17080319 sample preparation test solution in batches number, respectively at the 0th, 12,24,36 and 48h, by real It applies and is measured under example 1 " 2.1 " item.As a result glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin, The RSD value of nobiletin peak area is respectively 1.92%, 0.09%, 0.51%, 1.43%, 0.85%, 0.45%, and 6 kinds at swarming The RSD value of area is respectively less than 3%, shows that each ingredient is good in 48h internal stability in Tai Ji ageratum oral liquid.
4. sample recovery rate
Taking lot number is 17080319 sample, and precision weighs 6 parts, is separately added into the reference substance solution of sample equivalent, by this The method that invention provides prepares sample, again with methanol dilute every 1mL containing 0.0019,0.0500,0.0049,0.0100, The mixing test solution of the above-mentioned 6 kinds of ingredients of 0.0500 and 0.0031mg is measured by embodiment 1 " 2.1 " item, records peak area, Calculate mean sample recovery rate.As a result glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin, river skin Glycosides mean sample recovery rate difference 95.70%, 97.79%, 99.74%, 103.15%, 100.71%, 103.72%, RSD value Respectively 1.04%, 0.50%, 0.56%, 0.19%, 1.54%, 0.23%.
Embodiment 3
Sample measurement
1 batch of sample is handled in the present inventive method, by being measured under embodiment 1 " 2.1 " item, is calculated using external standard method sweet Hay-scented legumin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin, nobiletin content, be as a result respectively 0.007%, 0.251%, 0.221%, 0.279%, 0.540% and 0.009%.
Table 2 10 batches of Tai Ji ageratum oral liquid samples, 6 kinds of component contents
Finally, it is stated that the above examples are only used to illustrate the technical scheme of the present invention and are not limiting, although referring to compared with Good embodiment describes the invention in detail, those skilled in the art should understand that, it can be to skill of the invention Art scheme is modified or replaced equivalently, and without departing from the objective and range of technical solution of the present invention, should all be covered at this In the scope of the claims of invention.

Claims (10)

1. a kind of method of Multiple components content in HPLC method separation determination ageratum oral liquid, which is characterized in that described The chromatographic column that HPLC method uses is to be mixed in a certain ratio using silica matrix as filler with solution A and solution B as mobile phase progress Elution;The solution A is acetonitrile, and the solution B is phosphoric acid water;The ingredient includes that glycycoumarin, isoliquiritigenin, celery sugar are sweet One of careless glycosides, narirutin, liquiritin, nobiletin are a variety of.
2. the side of Multiple components content in a kind of HPLC method separation determination ageratum oral liquid according to claim 1 Method, which is characterized in that the mass concentration of the phosphoric acid water is 0.05%-0.15%.
3. the side of Multiple components content in a kind of HPLC method separation determination ageratum oral liquid according to claim 1 Method, which is characterized in that the flow velocity that the mobile phase carries out gradient elution is 0.5-1.5ml/min.
4. the side of Multiple components content in a kind of HPLC method separation determination ageratum oral liquid according to claim 1 Method, which is characterized in that detector wavelength 250-280nm.
5. the side of Multiple components content in a kind of HPLC method separation determination ageratum oral liquid according to claim 1 Method, which is characterized in that detector column temperature is 25-30 DEG C.
6. the side of Multiple components content in a kind of HPLC method separation determination ageratum oral liquid according to claim 1 Method, which is characterized in that condition of gradient elution are as follows:
The percent by volume of 0-10min, mobile phase A and Mobile phase B is 8-18:92-82;
The percent by volume of 10-15min, mobile phase A and Mobile phase B is 18-19:82-81;
The percent by volume of 15-17min, mobile phase A and Mobile phase B is 19:81;
The percent by volume of 17-23min, mobile phase A and Mobile phase B is 19-20:81-80;
The percent by volume of 23-27min, mobile phase A and Mobile phase B is 20:80;
The percent by volume of 27-30min, mobile phase A and Mobile phase B is 20-21:80-79;
The percent by volume of 30-35min, mobile phase A and Mobile phase B is 21:79;
The percent by volume of 35-38min, mobile phase A and Mobile phase B is 21-22:79-78;
The percent by volume of 38-41min, mobile phase A and Mobile phase B is 22-23:78-77;
The percent by volume of 41-45min, mobile phase A and Mobile phase B is 23-26:77-74;
The percent by volume of 45-51min, mobile phase A and Mobile phase B is 26-32:74-68;
The percent by volume of 51-54min, mobile phase A and Mobile phase B is 32-33:68-67;
The percent by volume of 54-62min, mobile phase A and Mobile phase B is 33-55:67-45;
The percent by volume of 62-72min, mobile phase A and Mobile phase B is 55-74:45-26;
The percent by volume of 72-75min, mobile phase A and Mobile phase B is 74-75:26-25;
The percent by volume of 75-77min, mobile phase A and Mobile phase B is 75:25;
The percent by volume of 77-80min, mobile phase A and Mobile phase B is 75-100:25-0;
The percent by volume of 80-83min, mobile phase A and Mobile phase B is 100:0;
The percent by volume of 83-85min, mobile phase A and Mobile phase B is 100-8:0-92.
7. Multiple components contain in a kind of HPLC method separation determination ageratum oral liquid according to claim 1-6 The method of amount, which is characterized in that steps are as follows:
1) prepare reference substance solution: weigh respectively suitable glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, Liquiritin, nobiletin add methanol solution dissolution that reference substance solution is prepared;
2) it prepares sample solution: weighing suitable ageratum oral liquid, diluted with methanol solution and sample solution is made;
3) the sample solution injection high performance liquid chromatograph of the reference substance solution and step 2) that take step 1) respectively is analyzed, and is remembered Chromatogram is recorded, calculates glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, Radix Glycyrrhizae in sample solution with external standard method Glycosides, nobiletin content.
8. a kind of for being separated by solid-liquid separation the reagent composition of Multiple components content in measurement ageratum oral liquid, feature exists In, the ingredient include glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin, one in nobiletin Kind is a variety of;The reagent composition uses reverse phase silica gel as stationary phase, using acetonitrile as reagent A, using phosphoric acid water as examination Agent B;The mass concentration of the phosphoric acid water is 0.05%-0.15%.
9. a kind of separation determination glycycoumarin, isoliquiritigenin, celery sugar liquiritin, narirutin, liquiritin and river skin simultaneously The HPLC method of glycosides content, which is characterized in that the chromatographic column that the HPLC method uses is using silica matrix as filler, with solution A and solution B are mixed in a certain ratio to be eluted for mobile phase;The solution A is acetonitrile, and the solution B is phosphoric acid water.
10. HPLC method according to claim 9, which is characterized in that condition of gradient elution are as follows:
The percent by volume of 0-10min, mobile phase A and Mobile phase B is 8-18:92-82;
The percent by volume of 10-15min, mobile phase A and Mobile phase B is 18-19:82-81;
The percent by volume of 15-17min, mobile phase A and Mobile phase B is 19:81;
The percent by volume of 17-23min, mobile phase A and Mobile phase B is 19-20:81-80;
The percent by volume of 23-27min, mobile phase A and Mobile phase B is 20:80;
The percent by volume of 27-30min, mobile phase A and Mobile phase B is 20-21:80-79;
The percent by volume of 30-35min, mobile phase A and Mobile phase B is 21:79;
The percent by volume of 35-38min, mobile phase A and Mobile phase B is 21-22:79-78;
The percent by volume of 38-41min, mobile phase A and Mobile phase B is 22-23:78-77;
The percent by volume of 41-45min, mobile phase A and Mobile phase B is 23-26:77-74;
The percent by volume of 45-51min, mobile phase A and Mobile phase B is 26-32:74-68;
The percent by volume of 51-54min, mobile phase A and Mobile phase B is 32-33:68-67;
The percent by volume of 54-62min, mobile phase A and Mobile phase B is 33-55:67-45;
The percent by volume of 62-72min, mobile phase A and Mobile phase B is 55-74:45-26;
The percent by volume of 72-75min, mobile phase A and Mobile phase B is 74-75:26-25;
The percent by volume of 75-77min, mobile phase A and Mobile phase B is 75:25;
The percent by volume of 77-80min, mobile phase A and Mobile phase B is 75-100:25-0;
The percent by volume of 80-83min, mobile phase A and Mobile phase B is 100:0;
The percent by volume of 83-85min, mobile phase A and Mobile phase B is 100-8:0-92.
CN201910524812.9A 2019-06-18 2019-06-18 Method for separating and measuring contents of various components in Huoxiang Zhengqi oral liquid by HPLC method Active CN110231418B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910524812.9A CN110231418B (en) 2019-06-18 2019-06-18 Method for separating and measuring contents of various components in Huoxiang Zhengqi oral liquid by HPLC method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910524812.9A CN110231418B (en) 2019-06-18 2019-06-18 Method for separating and measuring contents of various components in Huoxiang Zhengqi oral liquid by HPLC method

Publications (2)

Publication Number Publication Date
CN110231418A true CN110231418A (en) 2019-09-13
CN110231418B CN110231418B (en) 2022-08-05

Family

ID=67859456

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910524812.9A Active CN110231418B (en) 2019-06-18 2019-06-18 Method for separating and measuring contents of various components in Huoxiang Zhengqi oral liquid by HPLC method

Country Status (1)

Country Link
CN (1) CN110231418B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114200038A (en) * 2021-11-23 2022-03-18 太极集团重庆涪陵制药厂有限公司 Method for detecting compound content in wrinkled gianthyssop herb zhengqi oral liquid by liquid chromatography-mass spectrometry

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105699500A (en) * 2014-11-28 2016-06-22 天士力制药集团股份有限公司 A method of measuring contents of seven components in a Huoxiangzhengqi dripping pill through ultra-high performance liquid chromatography
CN107389821A (en) * 2017-07-25 2017-11-24 长江师范学院 A kind of method of active ingredient in measure ageratum oral liquid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105699500A (en) * 2014-11-28 2016-06-22 天士力制药集团股份有限公司 A method of measuring contents of seven components in a Huoxiangzhengqi dripping pill through ultra-high performance liquid chromatography
CN107389821A (en) * 2017-07-25 2017-11-24 长江师范学院 A kind of method of active ingredient in measure ageratum oral liquid

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
MIAOQING ZHAO等: "Systems Pharmacology Dissection of Multi-Scale Mechanisms of Action of Huo-Xiang-Zheng-Qi Formula for the Treatment of Gastrointestinal Diseases", 《FRONTIERS IN PHARMACOLOGY》 *
何祥伟: "HPLC法同时测定藿香正气水中五种标志成分", 《亚太传统医药》 *
余佳文等: "UPLC 同时测定藿香正气口服液中甘草苷、柚皮芸香苷、橙皮苷、甘草酸铵、厚朴酚、和厚朴酚的含量", 《中国中药杂志》 *
易伟等: "H PLC同时测定复方祖师麻片中8种有效成分的含量", 《南京中医药大学学报》 *
曾路等: "国产甘草的质量评价", 《药学学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114200038A (en) * 2021-11-23 2022-03-18 太极集团重庆涪陵制药厂有限公司 Method for detecting compound content in wrinkled gianthyssop herb zhengqi oral liquid by liquid chromatography-mass spectrometry
CN114200038B (en) * 2021-11-23 2023-08-29 太极集团重庆涪陵制药厂有限公司 Method for detecting compound content in agastache rugosa healthy qi oral liquid by liquid chromatography-mass spectrometry

Also Published As

Publication number Publication date
CN110231418B (en) 2022-08-05

Similar Documents

Publication Publication Date Title
US20230213487A1 (en) Fingerprint Detection Method for Pharmaceutical Preparation
CN104777249B (en) The method measuring effective ingredient amygdaloside content in cough syrup of loquat leaf
CN102233021B (en) Content measurement method for Chinese patent medicine prepared from sweet wormwood, honeysuckle and gardenia jasminoides fruit
CN103760278B (en) A kind of simultaneous quantitative detects the efficient liquid-phase chromatography method of six kinds of flavones ingredients in water polygonum flaccidum
CN104614456A (en) Method for simultaneously detecting main components of Naoxintong capsule in plasma
Xie et al. Simultaneous determination of six main components in Bushen Huoxue prescription by HPLC-CAD
CN109765319A (en) A kind of Liushen Pills HPLC fingerprint atlas detection method
CN104764820A (en) Method for determining content of active ingredients such as ephedrine hydrochloride and pseudoephedrine hydrochloride in pinellia ternata syrup
CN111089916B (en) Method for detecting content of paeoniflorin, liquiritin and ammonium glycyrrhizinate in radix bupleuri and radix paeoniae alba oral liquid
CN102998383B (en) Method for testing content of main components in Rhodiola rosea extracts
CN107389821A (en) A kind of method of active ingredient in measure ageratum oral liquid
CN110487948A (en) The content assaying method of plurality of active ingredients in a kind of Hedan tablet
CN110231418A (en) A kind of method of Multiple components content in HPLC method separation determination ageratum oral liquid
CN109633028A (en) The detection method of spice additive in a kind of special medicine purposes formula food
CN107643343B (en) HPLC fingerprint spectrum determination method of Yunv Jian standard soup
CN103424476A (en) Method for simultaneously determining four water-soluble components in polydanshinolic acid
CN110568111B (en) Method for detecting oligosaccharide in morinda officinalis formula particles
CN105651889B (en) The method of quality control of total phthalide lactone in a kind of rhizoma chuanxiong volatile oil
CN105510452B (en) Multi-target ingredient assay, fingerprint map construction and the preparation method of liver-benefiting eye-brightening oral liquid
CN103713067B (en) Ultra-high performance liquid chromatography method for determining content of rheum lhasaense
CN110441445A (en) A kind of construction method and flavones ingredient assay of cockscomb HPLC characteristic fingerprint pattern
CN103149299B (en) Method for quickly measuring content of flavonoid constituents in paniculata
CN108333289A (en) A kind of method of multi-analyte immunoassay control grub content
CN105823830B (en) One surveys the methods for commenting tanshin polyphenolic acid B and schizandrin content in method measurement Yixinfumai particle more
CN106706811A (en) Method for simultaneously detecting five triterpene acid components in Cornus officinalis by utilizing UFLC method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant